智通财经APP讯，*ST阳光(000608.SZ)公告，公司董事会审议通过了《关于拟申请撤销公司股票退市风 险警示的议案》，公司已于2月26日向深圳证券交易所提交了关于撤销对公司股票交易实施退市风险警 示的申请。 ...

智通财经APP讯，天立国际控股(01773)发布公告，该公司于2026年2月26日斥资51.2万港元回购20万股 股份，每股回购价格为2.56港元。 ...

智通财经APP讯，小米集团-W(01810)公布，2026年2月26日耗资约9999.68万港元回购283.22万股股份。 ...

Market Focus - The Southern Peninsula Palm Oil Millers Association (SPPOMA) reported that Malaysia's palm oil yield from February 1-25, 2026, decreased by 16.78% month-on-month, while the extraction rate increased by 0.1%, and production fell by 16.25% compared to the same period last month [1] - According to independent inspection agency AmSpec, Malaysia's palm oil exports from February 1-25 amounted to 922,649 tons, a decrease of 16.05% from 1,099,033 tons in the same period last month [1] - Shipping survey agency ITS reported that Malaysia's palm oil exports for the same period were 1,022,673 tons, down 12.1% from 1,163,634 tons last month [1] - The Malaysian Palm Oil Association (MPOA) estimated a 12.29% decrease in palm oil production from February 1-20, with reductions of 10.74% in Peninsular Malaysia, 15.23% in Sabah, 11.20% in Sarawak, and 14.19% in Borneo [1] - The Malaysian Palm Oil Council (MPOC) noted that despite challenges such as the delay of Indonesia's B50 biodiesel mandate and high Malaysian inventories, palm oil prices remained above 4,000 ringgit per ton throughout January, indicating a potential short-term structural bottom for current prices [1] Daily Oilseed Processing Data - In January 2026, Canada's canola processing volume was 1,053,420 tons, a decrease of 2.17% from the previous month but an increase of 4.24% year-on-year [2] OPEC+ Meeting Insights - OPEC+ representatives indicated that the organization is likely to agree on a slight production increase during the upcoming meeting to review April policies, with a potential increase of 137,000 barrels per day being considered for April [2] Market Review - The strong rise in U.S. soybeans, reaching a three-month high, provided significant support for soybean oil costs, while palm oil showed a weaker trend due to poor export data reflecting seasonal demand decline post-Ramadan [5] - As a result, the price spread between soybean oil and palm oil continued to adjust, with the main May contract spread approaching -500 yuan per ton at the close [5]

泰凌医药(01011)发布公告，预期本集团于截至2025年12月31日止年度(本年度)将取得本公司拥有人应占 亏损净额介乎约人民币2500万元至人民币3000万元，较截至2024年12月31日止年度(上一年度)取得的本 公司拥有人应占亏损净额约人民币5340万元，显著减少约43.8%至53.2%。 预期亏损减少主要归因于以下因素：上一年度因会计重分类而确认的围绕北京康辰生物科技有限公司股 权的一次性非现金公允价值亏损约人民币2950万元，于本年度不再出现;及按公允值计入损益的金融资 产(即上述股权)于本年度取得约人民币1400万元的公允价值收益。 ...

在此次获批之前，本公司的Geri胚胎培养液(Gems胚胎培养液系列产品之一)已分别取得欧洲合格认证 ("CE")、美国食品药品监督管理局(Food and Drug Administration)("FDA")认证及澳大利亚药品管理局 (Therapeutic Goods Administration)("TGA")认证。该产品之核心技术来源于悉尼体外受精中心。结合Geri 湿式时差培养箱与AI胚胎评估系统，Geri胚胎培养液已正式进入中国临床实践，以其抗氧化配方与稳定 渗透压环境的两大核心优势，解决了高龄患者胚胎培养的难题。 Geri胚胎培养液的技术核心在于针对高龄患者生育难点构建系统性解决方案。其"三重抗氧化防护网"能 有效应对高龄胚胎的氧化应激难题，配合提前添加人血清白蛋白与超长效期稳定性，大幅简化实验室操 作并确保培养环境稳定。国际临床验证显示，该培养液结合Geri湿式时差培养箱及AI胚胎评估系统，可 显着提升优质囊胚率与临床妊娠率，为高龄生育提供坚实保障。 贝康医疗-B(02170)发布公告，本公司的Geri胚胎培养液(Gems胚胎培养液系列产品之一)于2026年2月25 日获得中国国家药品监督管理 ...

Core Viewpoint - The company reported a significant decline in revenue and an increase in losses, primarily attributed to decreased sales from its flagship product, the Tianwang watch, amid ongoing international trade tensions and high tariffs imposed by the new U.S. government [1] Financial Performance - The company achieved revenue of HKD 281 million for the six months ending December 31, 2025, representing an 18.2% year-on-year decrease [1] - The loss attributable to owners for the period was HKD 36.85 million, a substantial increase of 237.67% compared to the previous year [1] - Basic loss per share was reported at 1.8 HKD cents [1] Market Conditions - The decline in revenue is primarily due to a drop in sales from the Tianwang watch, influenced by high tariffs on imports to the U.S., particularly those from China, which are above the average tariff rates [1] - Ongoing international trade disputes and tariff wars have negatively impacted China's economic growth and employment, further weakening consumer confidence in the Chinese retail market, which in turn affected product demand during the reporting period [1]

天立国际控股(01773)发布公告，该公司于2026年2月26日斥资51.2万港元回购20万股股份，每股回购价 格为2.56港元。 ...

Geri胚胎培养液的技术核心在于针对高龄患者生育难点构建系统性解决方案。其"三重抗氧化防护网"能 有效应对高龄胚胎的氧化应激难题，配合提前添加人血清白蛋白与超长效期稳定性，大幅简化实验室操 作并确保培养环境稳定。国际临床验证显示，该培养液结合Geri湿式时差培养箱及AI胚胎评估系统，可 显著提升优质囊胚率与临床妊娠率，为高龄生育提供坚实保障。 此次获批标志着公司实现从引进技术到本土化生产的关键跨越，填补国产高端辅助生殖耗材空白，成为 首个拥有FDA、CE、TGA、NMPA四大国际权威认证的中国企业。凭藉PGT核心技术及耗材自供能 力，公司已覆盖全国绝大部分PGT持牌机构，并设有数十家本地化实验室，形成持续迭代的生态壁垒。 格隆汇2月26日丨贝康医疗-B(02170.HK)公告，公司的Geri胚胎培养液(Gems胚胎培养液系列产品之一) 于2026年2月25日获得中国国家药品监督管理局("国家药监局")颁发的三类医疗器械注册证(注册证号： 国械注进20263180071)。 在此次获批前，公司的Geri胚胎培养液(Gems胚胎培养液系列产品之一)已分别取得欧洲合格认证 ("CE")、美国食品药品监督管理局(Fo ...

格隆汇2月26日丨天立国际控股(01773.HK)公告，2月26日耗资51.2万港元回购20万股。 ...